TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
ENTA

Enanta Pharmaceuticals Inc

Healthcare · Biotechnology

11.90$ -1.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Enanta Pharmaceuticals Inc (ENTA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 297 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet ENTA
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
462 428 414 399 377 349 323 301 281 330 315 297
423 390 351 287 300 268 243 223 204 199 178 204
85 40 64 36 37 84 60 45 32 37 35 33
370 337 300 230 248 217 193 204 189 186 164 190
40 40 40 41 39 40 41 8.4 6.9 8.5 7.8 6.5
– 0.0 0.0 0.0 – – – – – – – –
246 237 247 250 248 237 229 222 216 203 198 196
63 62 55 58 58 49 46 45 49 45 46 54
40 46 37 35 36 34 33 30 34 35 35 3.9
4.1 9.3 6.7 11 8.0 4.7 4.8 3.5 1.9 1.9 4.4 3.3
217 192 166 149 129 112 94 79 65 127 117 101
-207 -240 -272 -294 -323 -345 -368 -386 -405 -417 -430 -449
21 21 21 21 21 21 21 21 21 29 29 29

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?